Hauschild, A., Weichenthal, M., Rass, K., Linse, R., Ulrich, J., Stadler, R., . . . Garbe, C. (2009). Prospective randomized multicenter adjuvant Dermatologic Cooperative Oncology Group trial of low-dose interferon Alfa-2b with or without a modified high-dose interferon Alfa-2b induction phase in patients with lymph node-negative melanoma. Journal of clinical oncology. [Englische Ausgabe], 27(21), . https://doi.org/10.1200/JCO.2008.21.3892
Chicago-Zitierstil (17. Ausg.)Hauschild, Axel, et al. "Prospective Randomized Multicenter Adjuvant Dermatologic Cooperative Oncology Group Trial of Low-dose Interferon Alfa-2b with or Without a Modified High-dose Interferon Alfa-2b Induction Phase in Patients with Lymph Node-negative Melanoma." Journal of Clinical Oncology. [Englische Ausgabe] 27, no. 21 (2009). https://doi.org/10.1200/JCO.2008.21.3892.
MLA-Zitierstil (9. Ausg.)Hauschild, Axel, et al. "Prospective Randomized Multicenter Adjuvant Dermatologic Cooperative Oncology Group Trial of Low-dose Interferon Alfa-2b with or Without a Modified High-dose Interferon Alfa-2b Induction Phase in Patients with Lymph Node-negative Melanoma." Journal of Clinical Oncology. [Englische Ausgabe], vol. 27, no. 21, 2009, https://doi.org/10.1200/JCO.2008.21.3892.